Twist Bioscience (NASDAQ:TWST) Price Target Raised to $65.00

Twist Bioscience (NASDAQ:TWST – Free Report) had its price objective boosted by TD Cowen from $55.00 to $65.00 in a research note published on Thursday morning, Benzinga reports. They currently have a buy rating on the stock. TWST has been the subject of several other research reports. Guggenheim assumed coverage on shares of Twist Bioscience […]

Leave a Reply

Your email address will not be published.

Previous post Xencor (NASDAQ:XNCR) Rating Reiterated by Wedbush
Next post Tonix Pharmaceuticals (NASDAQ:TNXP) Research Coverage Started at StockNews.com